IP Law Daily, PATENT—D. Del.: Court dismisses Onego Bio's patent and false advertising claims, (Oct 14, 2026)
Law Firms Mentioned:Potter Anderson & Corroon, LLP | Stamoulis & Weinblatt LLC
Organizations Mentioned:Clara Foods Co. | Onego Bio Inc.
By Patricia K. Ruiz, J.D.
Onego failed to establish patent jurisdiction and standing for its Lanham Act claims.
A Delaware federal court dismissed all claims brought by Onego Bio Inc. against Clara Foods Co., doing business as The EVERY Company, concluding that no actual patent controversy existed when the suit was filed and that Onego failed to establish standing or adequately plead its unfair competition claims. The court held that EVERY had not taken affirmative steps to enforce its patent rights against Onego and that Onego's allegations of commercial and reputational injury were insufficient. The court granted EVERY's motion to dismiss the amended complaint in its entirety (Onega Bio, Inc. v. Clara Foods Co. d/b/a The Every Co., No. 1:25-cv-01131-JDW (D. Del. Oct. 9, 2026)).
No actual controversy over patent rights. Onego sought declarations that U.S. Patent No. 12,096,784, covering recombinant ovalbumin protein compositions, was invalid and unenforceable and that its products did not infringe the patent. The company argued that statements made by EVERY during licensing and business discussions, as well as alleged comments to investors, created a sufficient controversy to support declaratory judgment jurisdiction.
The court rejected that argument, finding that the record showed Onego initiated discussions and repeatedly threatened patent invalidation proceedings unless EVERY agreed to cross-licensing arrangements. According to the court, EVERY consistently responded by expressing confidence in its patent portfolio and pursuing business resolutions rather than threatening litigation. The court emphasized that EVERY never accused Onego of infringing the patent at issue, never identified specific claims allegedly infringed, and expressly declined to provide intellectual-property guidance concerning how its patents might apply to Onego. The court concluded that EVERY committed no affirmative act asserting patent rights against Onego sufficient to create a justiciable controversy under the Declaratory Judgment Act.
The court further found that alleged statements conveyed through investors lacked evidentiary weight and, even if considered, appeared more consistent with business promotion and acquisition discussions than with imminent patent enforcement.
Lanham Act standing not established. Onego further alleged that EVERY falsely advertised its animal-free egg proteins as "equivalent," "bio-identical," and "nature-equivalent" to natural egg proteins despite alleged amino-acid differences. Onego claimed those statements harmed its business and prospective market opportunities.
The court held that Onego failed to plead an injury to a commercial interest in sales or business reputation proximately caused by the challenged statements. The amended complaint alleged only that Onego had shipped products to the United States while continuing efforts to build a planned Wisconsin manufacturing facility. The court found those allegations insufficient to plausibly show lost sales, diversion of customers, or direct competitive injury in the U.S. market.
The court determined that Onego failed to allege facts plausibly showing reputational harm to its own products. Assertions that EVERY's statements could generally harm the developing animal-free egg protein market did not establish the type of commercial injury required under the Lanham Act, the court said. Because Onego failed to adequately plead proximate causation and commercial injury, the court concluded that it lacked statutory standing to pursue its false advertising claim and had failed to state a claim for relief.
Tortious interference claim dismissed. The court dismissed any tortious interference claim that could be inferred from the amended complaint. Although Onego referenced interference with economic relationships, it did not plead a separate tortious interference count and did not respond to EVERY's dismissal arguments. The court treated the issue as conceded and found the allegations too vague and conclusory to state a claim under Delaware law.
The Case is No. 1:25-cv-01131-JDW.
Judge: Wolson, J.
Attorneys: Stamatios Stamoulis (Stamoulis & Weinblatt LLC) for Onego Bio Inc. Bindu Ann George Palapura (Potter Anderson & Corroon, LLP) for Clara Foods Co.
Companies: Onego Bio Inc.; Clara Foods Co.
Cases: Patent DelawareNews